 | • レポートコード：MRC2302F0015 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、244ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に144.9億ドルであった世界の美容医療市場規模が、2022年に162.4億ドルになり、2027年には289.6億ドルまで、年平均12.23%で成長すると予測しています。本レポートでは、美容医療の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、機能別（化学的剥離、ダーマルフィラー、レーザ、脂肪吸引機、その他）分析、治療別（アンチエイジング＆シワ、ボディシェイピング&セルライト、フェイシャル＆スキンリジュビネーション、乾癬、その他）分析、製品別（体型矯正装置、美容インプラント、脱毛器、美肌器、その他）分析、エンドユーザー別（皮膚科＆化粧品センター、病院＆クリニック、メディカルスパ&ビューティー センター）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、Allergan PLC、Alma Lasers, Ltd.、Anika Therapeutics, Inc.、Candela Corporation、Cutera, Inc.、Cynosure, LLC、Fotona d.o.o.、Galderma S.A.、Groupe Sebbin SAS、Institut Straumann AG、Johnson & Johnson、Medytox, Inc.、Merz Aesthetics, Inc.、Motiva by Establishment Labs Holdings Inc.、Nobel Biocare Services AG、Quanta System by El.En. S.P.A.、Sientra, Inc.、Sinclair Pharma PLC、Solta Medical International, Inc. by Bosch Healthcare Solutions GmbHなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の美容医療市場規模：機能別 - 化学的剥離の市場規模 - ダーマルフィラーの市場規模 - レーザの市場規模 - 脂肪吸引機の市場規模 - その他機能の市場規模 ・世界の美容医療市場規模：治療別 - アンチエイジング＆シワ治療の市場規模 - ボディシェイピング&セルライト治療の市場規模 - フェイシャル＆スキンリジュビネーション治療の市場規模 - 乾癬治療の市場規模 - その他治療の市場規模 ・世界の美容医療市場規模：製品別 - 体型矯正装置の市場規模 - 美容インプラントの市場規模 - 脱毛器の市場規模 - 美肌器の市場規模 - その他製品の市場規模 ・世界の美容医療市場規模：エンドユーザー別 - 皮膚科＆化粧品センターにおける市場規模 - 病院＆クリニックにおける市場規模 - メディカルスパ&ビューティー センターにおける市場規模 ・世界の美容医療市場規模：地域別 - 南北アメリカの美容医療市場規模 アメリカの美容医療市場規模 カナダの美容医療市場規模 ブラジルの美容医療市場規模 ... - アジア太平洋の美容医療市場規模 日本の美容医療市場規模 中国の美容医療市場規模 インドの美容医療市場規模 韓国の美容医療市場規模 台湾の美容医療市場規模 ... - ヨーロッパ/中東/アフリカの美容医療市場規模 イギリスの美容医療市場規模 ドイツの美容医療市場規模 インドの美容医療市場規模 フランスの美容医療市場規模 ロシアの美容医療市場規模 ... - その他地域の美容医療市場規模 ・競争状況 ・企業情報 |
The Global Medical Aesthetics Market size was estimated at USD 14.49 billion in 2021 and expected to reach USD 16.24 billion in 2022, and is projected to grow at a CAGR 12.23% to reach USD 28.96 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Medical Aesthetics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the market was studied across Chemical Peel, Dermal Filler, Laser, Liposuction Machine, Needling, Cellulite & Fat Reduction, and Skin Tightening & Resurfacing.
Based on Treatment, the market was studied across Anti-Aging & Wrinkles, Body Shaping & Cellulite, Breast Enhancement, Facial & Skin Rejuvenation, Pigment Lesions, Psoriasis, Reconstructive, Sears, Tattoo Removal, Vascular Lesions, and Vitiligo.
Based on Product, the market was studied across Body Contouring Device, Aesthetic Implant, Facial Aesthetic Product, Hair Removal Device, Nail Treatment Laser Device, Skin Aesthetic Device, Tattoo Removal Device, and Thread Lift Product.
Based on Operation, the market was studied across Non-Surgical and Surgical.
Based on End User, the market was studied across Dermatology & Cosmetic Center, Hospital & Clinic, and Medical Spa & Beauty Center.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Medical Aesthetics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Medical Aesthetics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Medical Aesthetics Market, including Allergan PLC, Alma Lasers, Ltd., Anika Therapeutics, Inc., Candela Corporation, Cutera, Inc., Cynosure, LLC, Fotona d.o.o., Galderma S.A., Groupe Sebbin SAS, Institut Straumann AG, Johnson & Johnson, Medytox, Inc., Merz Aesthetics, Inc., Motiva by Establishment Labs Holdings Inc., Nobel Biocare Services AG, Quanta System by El.En. S.P.A., Sientra, Inc., Sinclair Pharma PLC, and Solta Medical International, Inc. by Bosch Healthcare Solutions GmbH.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Medical Aesthetics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Medical Aesthetics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Medical Aesthetics Market?
4. What is the competitive strategic window for opportunities in the Global Medical Aesthetics Market?
5. What are the technology trends and regulatory frameworks in the Global Medical Aesthetics Market?
6. What is the market share of the leading vendors in the Global Medical Aesthetics Market?
7. What modes and strategic moves are considered suitable for entering the Global Medical Aesthetics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of minimally invasive and noninvasive aesthetic procedures
5.1.1.2. Rising adoption among geriatric individuals and increasing aesthetic treatments among men
5.1.1.3. Introduction of technologically advanced and easy to use product
5.1.1.4. Rising incidences of skin diseases and increasing expenditure on cosmetic
5.1.2. Restraints
5.1.2.1. Availability of alternative beauty and cosmetic products
5.1.2.2. Social and cultural barriers in certain emerging economies
5.1.3. Opportunities
5.1.3.1. Growing adoption of aesthetic devices for home use due to development of low cost devices
5.1.3.2. Rising medical tourism
5.1.3.3. Potential in middle class population owing to increasing disposable income
5.1.4. Challenges
5.1.4.1. Associated clinical risk and medical complications
5.1.4.2. High cost associated with the treatment and lack of reimbursement policies
5.2. Cumulative Impact of COVID-19
6. Medical Aesthetics Market, by Function
6.1. Introduction
6.2. Chemical Peel
6.3. Dermal Filler
6.4. Laser
6.5. Liposuction Machine
6.6. Needling
6.7. Cellulite & Fat Reduction
6.8. Skin Tightening & Resurfacing
7. Medical Aesthetics Market, by Treatment
7.1. Introduction
7.2. Anti-Aging & Wrinkles
7.3. Body Shaping & Cellulite
7.4. Breast Enhancement
7.5. Facial & Skin Rejuvenation
7.6. Pigment Lesions
7.7. Psoriasis
7.8. Reconstructive
7.9. Sears
7.10. Tattoo Removal
7.11. Vascular Lesions
7.12. Vitiligo
8. Medical Aesthetics Market, by Product
8.1. Introduction
8.2. Body Contouring Device
8.3. Aesthetic Implant
8.4. Facial Aesthetic Product
8.5. Hair Removal Device
8.6. Nail Treatment Laser Device
8.7. Skin Aesthetic Device
8.8. Tattoo Removal Device
8.9. Thread Lift Product
9. Medical Aesthetics Market, by Operation
9.1. Introduction
9.2. Non-Surgical
9.3. Surgical
10. Medical Aesthetics Market, by End User
10.1. Introduction
10.2. Dermatology & Cosmetic Center
10.3. Hospital & Clinic
10.4. Medical Spa & Beauty Center
11. Americas Medical Aesthetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Medical Aesthetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Medical Aesthetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Allergan PLC
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Alma Lasers, Ltd.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Anika Therapeutics, Inc.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Candela Corporation
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Cutera, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Cynosure, LLC
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Fotona d.o.o.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Galderma S.A.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Groupe Sebbin SAS
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Institut Straumann AG
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Johnson & Johnson
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Medytox, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Merz Aesthetics, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Motiva by Establishment Labs Holdings Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Nobel Biocare Services AG
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Quanta System by El.En. S.P.A.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Sientra, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Sinclair Pharma PLC
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Solta Medical International, Inc. by Bosch Healthcare Solutions GmbH
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing